ESG Report 2025

15 The United Laboratories firmly believes that a standardised and transparent governance system, together with disciplined and ethical business conduct, forms the fundamental basis for earning trust and achieving sustainable development. In the face of increasingly stringent regulation in the pharmaceutical industry and a complex and fast-changing market environment, we consistently regard compliant operations as a lifeline and place risk prevention and control at a strategic level. By continuously improving our governance structure, strengthening internal control and upholding business ethics, we lay a solid foundation for the steady development of the Group. We recognise that excellent governance is not only about compliance with rules, but also about responding to stakeholders' expectations. To this end, the Group has established a comprehensive risk management system covering strategic, operational, financial and compliance areas. Through the systematic identification, assessment and response to internal and external risks, we strive to ensure steady and resilient operations in a dynamic business environment. At the same time, we promote business ethics with a zero-tolerance approach, integrating a culture of integrity into every aspect of daily operations and working together with our partners to maintain a fair, transparent and healthy business ecosystem.This chapter sets out our philosophy and practices in safeguarding development through compliance across six dimensions: risk management, internal control, business ethics, information security and data protection, intellectual property management, and medical ethics. Basic Standard for Enterprise Internal Control Application Guidelines for Enterprise Internal Control Rules of Procedure of the Risk Management Committee Area Relevant Laws, Regulations and Standards Internal Policies Risk Management Internal Control International Standards for the Professional Practice of Internal Auditing Audit Law of the People's Republic of China Provisions of the National Audit Office on Internal Audit Work Internal Audit Charter of The United Laboratories International Holdings Limited Annual Work Plan of the Audit Centre Audit Quality Control Procedures Business Ethics Criminal Law of the People's Republic of China Anti-Unfair Competition Law of the People's Republic of China Anti-Money Laundering Law of the People's Republic of China Interim Provisions on Banning Commercial Bribery The United Laboratories Code of Business Conduct The United Laboratories Employees' Code of Integrity and Self-Discipline The United Laboratories Anti-Fraud and Whistleblowing Management Policy Integrity Cooperation Agreement The United Laboratories Anti-Money Laundering Management Policy Conflict of Interest Declaration and Management Policy Compliance Incident Reporting Policy Information Security and Data Protection Cybersecurity Law of the People's Republic of China Data Security Law of the People's Republic of China Personal Information Protection Law of the People's Republic of China Law of the People's Republic of China on the Protection of Consumer Rights and Interests Information Security Technology – Baseline for Classified Protection of Cybersecurity Good Clinical Practice The United Laboratories Information Management Policy Working System of the Information Security Management Committee Emergency Operation Procedures for Power Outage in Server Rooms Privacy Policy of The United Laboratories International Holdings Limited Personal Information Security and Privacy Protection Policy The United Laboratories Patient Information Protection Policy Privacy Protection Policy for Trial Subjects Intellectual Property Management Patent Law of the People's Republic of China Trademark Law of the People's Republic of China Copyright Law of the People's Republic of China Anti-Unfair Competition Law of the People's Republic of China The United Laboratories Intellectual Property Management Policy The United Laboratories Information Management Policy Medical Ethics Civil Code of the People's Republic of China Drug Administration Law of the People's Republic of China Measures for the Administration of Drug Registration Good Clinical Practice Measures for Ethical Review of Life Sciences and Medical Research Involving Human Subjects World Medical Association Declaration of Helsinki Pharmaceutical Representative Filing and Review Management System Patient Personal Information Protection System Subject Privacy Protection System The United Laboratories International Holdings Limited 2025 Environmental, Social and Governance Report